Australia · Delayed Price · Currency is AUD Clinuvel Pharmaceuticals Statistics
Total Valuation
ASX:CUV has a market cap or net worth of AUD 413.51 million. The enterprise value is 163.39 million.
| Market Cap | 413.51M |
| Enterprise Value | 163.39M |
Important Dates
The last earnings date was Thursday, August 27, 2026.
| Earnings Date | Aug 27, 2026 |
| Ex-Dividend Date | Sep 3, 2026 |
Share Statistics
ASX:CUV has 50.43 million shares outstanding. The number of shares has increased by 0.73% in one year.
| Current Share Class | 50.43M |
| Shares Outstanding | 50.43M |
| Shares Change (YoY) | +0.73% |
| Shares Change (QoQ) | +0.51% |
| Owned by Insiders (%) | 7.55% |
| Owned by Institutions (%) | 25.94% |
| Float | 44.03M |
Valuation Ratios
The trailing PE ratio is 12.28 and the forward PE ratio is 12.04. ASX:CUV's PEG ratio is 1.48.
| PE Ratio | 12.28 |
| Forward PE | 12.04 |
| PS Ratio | 4.40 |
| PB Ratio | 1.52 |
| P/TBV Ratio | 1.52 |
| P/FCF Ratio | 11.71 |
| P/OCF Ratio | 11.20 |
| PEG Ratio | 1.48 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.94, with an EV/FCF ratio of 4.63.
| EV / Earnings | 4.82 |
| EV / Sales | 1.74 |
| EV / EBITDA | 3.94 |
| EV / EBIT | 4.03 |
| EV / FCF | 4.63 |
Financial Position
The company has a current ratio of 14.81, with a Debt / Equity ratio of 0.01.
| Current Ratio | 14.81 |
| Quick Ratio | 14.34 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | 0.05 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 13.21% and return on invested capital (ROIC) is 126.71%.
| Return on Equity (ROE) | 13.21% |
| Return on Assets (ROA) | 8.94% |
| Return on Invested Capital (ROIC) | 126.71% |
| Return on Capital Employed (ROCE) | 14.69% |
| Weighted Average Cost of Capital (WACC) | 7.40% |
| Revenue Per Employee | 5.88M |
| Profits Per Employee | 2.12M |
| Employee Count | 16 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 2.01 |
Taxes
In the past 12 months, ASX:CUV has paid 13.74 million in taxes.
| Income Tax | 13.74M |
| Effective Tax Rate | 28.84% |
Stock Price Statistics
The stock price has decreased by -35.02% in the last 52 weeks. The beta is 0.58, so ASX:CUV's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | -35.02% |
| 50-Day Moving Average | 8.87 |
| 200-Day Moving Average | 9.91 |
| Relative Strength Index (RSI) | 44.46 |
| Average Volume (20 Days) | 133,669 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:CUV had revenue of AUD 94.02 million and earned 33.92 million in profits. Earnings per share was 0.67.
| Revenue | 94.02M |
| Gross Profit | 78.21M |
| Operating Income | 40.53M |
| Pretax Income | 47.66M |
| Net Income | 33.92M |
| EBITDA | 41.11M |
| EBIT | 40.53M |
| Earnings Per Share (EPS) | 0.67 |
Balance Sheet
The company has 252.06 million in cash and 1.94 million in debt, with a net cash position of 250.12 million or 4.96 per share.
| Cash & Cash Equivalents | 252.06M |
| Total Debt | 1.94M |
| Net Cash | 250.12M |
| Net Cash Per Share | 4.96 |
| Equity (Book Value) | 272.88M |
| Book Value Per Share | 5.41 |
| Working Capital | 265.41M |
Cash Flow
In the last 12 months, operating cash flow was 36.91 million and capital expenditures -1.60 million, giving a free cash flow of 35.31 million.
| Operating Cash Flow | 36.91M |
| Capital Expenditures | -1.60M |
| Depreciation & Amortization | 576,594 |
| Net Borrowing | -238,643 |
| Free Cash Flow | 35.31M |
| FCF Per Share | 0.70 |
Margins
Gross margin is 83.18%, with operating and profit margins of 43.11% and 36.07%.
| Gross Margin | 83.18% |
| Operating Margin | 43.11% |
| Pretax Margin | 50.69% |
| Profit Margin | 36.07% |
| EBITDA Margin | 43.72% |
| EBIT Margin | 43.11% |
| FCF Margin | 37.55% |
Dividends & Yields
This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 0.61%.
| Dividend Per Share | 0.05 |
| Dividend Yield | 0.61% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 7.39% |
| FCF Payout Ratio | 7.14% |
| Buyback Yield | -0.73% |
| Shareholder Yield | -0.12% |
| Earnings Yield | 8.20% |
| FCF Yield | 8.54% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for ASX:CUV is 17.36, which is 111.71% higher than the current price. The consensus rating is "Buy".
| Price Target | 17.36 |
| Price Target Difference | 111.71% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 13.79% |
| EPS Growth Forecast (3Y) | 15.00% |
Stock Splits
The last stock split was on November 12, 2010. It was a reverse split with a ratio of 0.1.
| Last Split Date | Nov 12, 2010 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
ASX:CUV has an Altman Z-Score of 17.18 and a Piotroski F-Score of 5.
| Altman Z-Score | 17.18 |
| Piotroski F-Score | 5 |